
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CCR Translations |
Author's Affiliation: University of Texas M. D. Anderson Cancer Center, Houston, Texas
Requests for reprints: Jean-Pierre Issa, Department of Leukemia, M. D. Anderson Cancer Center, Unit 428, 1515 Holcombe, Houston, TX 77030. Phone: 713-745-2260; Fax: 713-794-4297; E-mail: jpissa{at}mdanderson.org.
Abstract
Combined genetic and epigenetic analysis of sporadic colon cancer suggest that it can no longer be viewed as a single disease. There are at least three different subsets with distinct clinico-pathologic features, with important implications for preventions, screening, and therapy.
Key Article
Clin. Cancer Res. 2008 14: 6005-6013.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |